Quest Medical Imaging BV has been rewarded an EU Excel grant with a total vallue of 29 mln euro’s. The three year program has started on May 1st this year.
EXIST addresses societal needs in the automotive, agriculture, security, professional broadcast and healthcare markets. These needs will be addressed by improving the performance of advanced image capturing systems at the different levels of an imaging system:
- Image sensors;
- Video processing inside camera systems;
Improved image quality will allow for the extraction of more detailed information and a wider range of applicability such as.
- Professional Broadcast Media, and
- Automotive applications.
New technologies will be developed at the imager process technology level and the imaging and vision system design. Their relevance will be demonstrated in a number of applications.
The developed technologies will enable new vision systems answering societal needs,
To minimize potential complications of open surgery, as a diagnostic and interventional procedure, the current healthcare tendency is to move towards robotic image-guided laparoscopic surgery. However, when spatial perception from direct sight and haptic feedback from direct touch are lacking, identification of critical tissues becomes extremely challenging. This can be tackled by e.g., increasing field-of-view and providing image enhancement and classification of critical tissues.
For example, tumour resection region is particularly challenging for the human eye and it often needs to be evaluated afterwards with high probability to either extensive and damaging resection or reoperation. Therefore, a reliable tool to enhance the contrast of between critical tissues is desirable for improved results of laparoscopic procedures. Exploring optical spectroscopy techniques might offer a roadmap towards such a tool, as all tissue types differ in their spectral finger print. Using advanced and multi-modal laparoscopy, by adding a HD hyperspectral imaging on top of current RGB video and by extending data processing to support advanced decision support, will add enormously to disease outcome and patient wellbeing and cutting costs at the same time.